Regulation_NN of_IN Focal_NP Adhesion_NP Kinase_NP by_IN a_DT Novel_NP Protein_NP Inhibitor_NP FIP200_NP Focal_NP adhesion_NN kinase_NN (_( FAK_NP )_) is_VBZ a_DT major_JJ mediator_NN of_IN integrin_NN signaling_VBG pathways_NNS ._SENT The_DT mechanisms_NNS of_IN regulation_NN of_IN FAK_NP activity_NN and_CC its_PP$ associated_VBN cellular_JJ functions_NNS are_VBP not_RB very_RB well_RB understood_VBN ._SENT Here_RB ,_, we_PP present_VBP data_NNS suggesting_VBG that_IN a_DT novel_NN protein_NN FIP200_NP functions_NNS as_IN an_DT inhibitor_NN for_IN FAK_NP ._SENT We_PP show_VBP the_DT association_NN of_IN endogenous_JJ FIP200_NP with_IN FAK_NP ,_, which_WDT is_VBZ decreased_VBN upon_IN integrin-mediated_JJ cell_NN adhesion_NN concomitant_NN with_IN FAK_NP activation_NN ._SENT In_IN vitro-_NN and_CC in_IN vivo-binding_NN studies_NNS indicate_VBP that_IN FIP200_NP interacts_VBZ with_IN FAK_NP through_IN multiple_JJ domains_NNS directly_RB ._SENT FIP200_NP bound_VBD to_TO the_DT kinase_NN domain_NN of_IN FAK_NP inhibited_VBD its_PP$ kinase_NN activity_NN in_IN vitro_NP and_CC its_PP$ autophosphorylation_NN in_IN vivo_RB ._SENT Overexpression_NN of_IN FIP200_NP or_CC its_PP$ segments_NNS inhibited_VBD cell_NN spreading_VBG ,_, cell_NN migration_NN ,_, and_CC cell_NN cycle_NN progression_NN ,_, which_WDT correlated_VBD with_IN their_PP$ inhibition_NN of_IN FAK_NP activity_NN in_IN vivo_RB ._SENT The_DT inhibition_NN of_IN these_DT cellular_JJ functions_NNS by_IN FIP200_NP could_MD be_VB rescued_VBN by_IN coexpression_NN of_IN FAK_NP ._SENT Last_RB ,_, we_PP show_VBP that_DT disruption_NN of_IN the_DT functional_JJ interaction_NN between_IN endogenous_JJ FIP200_NP with_IN FAK_NP leads_VBZ to_TO increased_VBN FAK_NP phosphorylation_NN and_CC partial_JJ restoration_NN of_IN cell_NN cycle_NN progression_NN in_IN cells_NNS plated_VBN on_IN poly-l-lysine_NN ,_, providing_VBG further_JJR support_NN for_IN FIP200_NP as_IN a_DT negative_JJ regulator_NN of_IN FAK_NP ._SENT Together_RB ,_, these_DT results_NNS identify_VBP FIP200_NP as_IN a_DT novel_JJ protein_NN inhibitor_NN for_IN FAK_NP ._SENT Focal_JJ adhesion_NN kinase_NN (_( FAK_NP )_) is_VBZ a_DT major_JJ mediator_NN of_IN signal_NN transduction_NN by_IN integrins_NNS ,_, which_WDT has_VBZ been_VBN implicated_VBN in_IN the_DT regulation_NN of_IN cell_NN spreading_VBG ,_, migration_NN ,_, survival_NN ,_, and_CC proliferation_NN ._SENT FAK_NP activation_NN and_CC tyrosine_NN phosphorylation_NN have_VBP been_VBN shown_VBN in_IN a_DT variety_NN of_IN cell_NN types_NNS to_TO be_VB dependent_JJ on_IN integrins_NNS binding_VBG to_TO their_PP$ extracellular_JJ ligands_NNS ._SENT On_IN its_PP$ activation_NN ,_, FAK_NP is_VBZ autophosphorylated_JJ at_IN Y397_NP ,_, which_WDT mediates_VBZ FAK_NP association_NN with_IN a_DT number_NN of_IN Src_NP homology_NN 2_CD (_( SH2_NP )_) domain-containing_NN signaling_VBG molecules_NNS ,_, including_VBG Src_NP family_NN kinases_NNS ,_, p85_JJ subunit_NN of_IN PI3K_NP ,_, phospholipase_NN C-gamma_NP ,_, and_CC Grb7_JJ ._SENT FAK_NP binding_VBG to_TO Src_NP family_NN kinases_NNS has_VBZ been_VBN proposed_VBN to_TO allow_VB phosphorylation_NN of_IN Y925_NP of_IN FAK_NP by_IN Src_NP ,_, which_WDT binds_VBZ to_TO the_DT SH2_JJ domain_NN of_IN Grb2_NP ._SENT The_DT FAK/Src_NP complex_JJ formation_NN also_RB leads_VBZ to_TO tyrosine_NN phosphorylation_NN of_IN a_DT number_NN of_IN other_JJ substrates_NNS ,_, including_VBG paxillin_NN ,_, p130cas_NNS ,_, and_CC Shc_NP ._SENT Recent_JJ studies_NNS have_VBP shown_VBN that_IN Grb7_NP is_VBZ phosphorylated_JJ by_IN FAK_NP in_IN a_DT Src-independent_NP manner_NN ._SENT FAK_NP and_CC its_PP$ downstream_JJ signaling_VBG pathways_NNS have_VBP been_VBN shown_VBN to_TO play_VB important_JJ roles_NNS in_IN the_DT regulation_NN of_IN cell_NN spreading_VBG and_CC migration_NN ._SENT FAK-/-_NN fibroblasts_NNS derived_VBN from_IN FAK-knockout_NP mouse_NN embryo_NN showed_VBD a_DT significant_JJ decrease_NN in_IN cell_NN migration_NN compared_VBN with_IN the_DT cells_NNS from_IN wild-type_NN mice_NNS ._SENT Similarly_RB ,_, inhibition_NN of_IN FAK_NP by_IN the_DT FAK_NP C-terminal_NP recombinant_JJ protein_NN (_( i.e._FW ,_, FRNK_NP )_) caused_VBD decreased_VBN motility_NN of_IN both_DT fibroblasts_NNS and_CC endothelial_JJ cells_NNS ,_, as_RB well_RB as_IN a_DT reduced_VBN rate_NN of_IN fibroblast_NN spreading_VBG ._SENT Last_JJ ,_, overexpression_NN of_IN FAK_NP in_IN a_DT number_NN of_IN cell_NN lines_NNS ,_, including_VBG the_DT FAK-/-_NP cells_NNS ,_, promoted_VBD their_PP$ migration_NN on_IN fibronectins_NNS (_( FN_NP )_) ._SENT FAK_NN signaling_VBG pathways_NNS have_VBP also_RB been_VBN shown_VBN to_TO regulate_VB cell_NN survival_NN and_CC cell_NN cycle_NN progression_NN in_IN integrin-mediated_JJ cell_NN adhesion_NN ._SENT Overexpression_NN of_IN FAK_NP protected_VBN cells_NNS from_IN apoptosis_NN induced_VBN by_IN cell_NN detachment_NN ,_, serum_NN withdraw_VB ,_, or_CC other_JJ treatments_NNS in_IN MDCK_NP cells_NNS or_CC primary_JJ fibroblasts_NNS ._SENT Conversely_RB ,_, inhibition_NN of_IN FAK_NP by_IN treatment_NN of_IN tumor_NN cell_NN lines_NNS with_IN FAK_NP antisense_NN oligonucleotides_NNS or_CC by_IN microinjection_NN of_IN CEF_NP cells_NNS with_IN an_DT anti-FAK_NP monoclonal_NN antibody-_NN (_( mAb_VB ;_: )_) induced_VBD apoptosis_NN ._SENT Microinjection_NN of_IN the_DT C-terminal_JJ fragment_NN of_IN FAK_NP into_IN either_DT fibroblasts_NNS or_CC endothelial_JJ cells_NNS inhibited_VBD cell_NN cycle_NN progression_NN as_IN measured_VBN by_IN bromodeoxyuridine_NN (_( BrdU_NP )_) incorporation_NN ._SENT Inhibition_NN of_IN FAK_NP tyrosine_NN phosphorylation_NN by_IN disruption_NN of_IN FN_NP matrix_NN assembly_NN also_RB resulted_VBD in_IN the_DT delay_NN of_IN the_DT G1_NP to_TO S_NP transition_NN ,_, suggesting_VBG a_DT role_NN for_IN FAK_NP in_IN cell_NN cycle_NN progression_NN ._SENT Finally_RB ,_, using_VBG a_DT tetracycline-regulated_JJ expression_NN system_NN ,_, we_PP have_VBP shown_VBN recently_RB that_DT expression_NN of_IN wild-type_NP FAK_NP accelerated_VBD G1_NP to_TO S_NP transition_NN ,_, whereas_IN expression_NN of_IN a_DT dominant_JJ negative_JJ FAK_NP mutant_NN inhibited_VBD cell_NN cycle_NN progression_NN at_IN G1_JJ phase_NN ._SENT In_IN contrast_NN to_TO rapid_JJ progress_NN in_IN elucidating_VBG the_DT FAK_NP downstream_IN signaling_VBG pathways_NNS ,_, relatively_RB little_RB is_VBZ known_VBN about_IN the_DT mechanisms_NNS of_IN regulation_NN of_IN FAK_NP activity_NN and_CC its_PP$ associated_VBN cellular_JJ functions_NNS ._SENT Using_VBG the_DT yeast_NN two-hybrid_NN screen_NN ,_, we_PP have_VBP recently_RB identified_VBN a_DT novel_NN protein_NN ,_, FAK-family_RB interacting_VBG protein_NN of_IN 200_CD kDa_NN (_( FIP200_NP )_) ,_, that_WDT is_VBZ associated_VBN with_IN the_DT FAK-related_JJ tyrosine_NN kinase_NN Pyk2_NN ._SENT Our_PP$ initial_JJ analysis_NN indicated_VBD that_IN FIP200_NP could_MD inhibit_VB the_DT kinase_NN and_CC cellular_JJ activity_NN of_IN Pyk2_NP by_IN binding_VBG to_TO its_PP$ kinase_NN domain_NN directly_RB ._SENT Furthermore_RB ,_, FIP200_NP could_MD also_RB bind_VB to_TO FAK_NP ._SENT Interestingly_RB ,_, both_DT FIP200_NP and_CC FAK_NP are_VBP widely_RB expressed_VBN in_IN a_DT variety_NN of_IN tissues_NNS and_CC cell_NN lines_NNS in_IN contrast_NN to_TO the_DT limited_JJ expression_NN pattern_NN of_IN Pyk2_NP ._SENT This_DT suggests_VBZ a_DT potentially_RB important_JJ role_NN for_IN FIP200_NP 's_POS interaction_NN with_IN FAK_NP in_IN some_DT fundamental_JJ cellular_JJ functions_NNS ._SENT In_IN this_DT report_NN ,_, we_PP show_VBP that_IN FIP200_NP could_MD also_RB bind_VB to_TO the_DT kinase_NN domain_NN of_IN FAK_NP and_CC function_NN as_IN a_DT protein_NN inhibitor_NN for_IN FAK_NP kinase_NN activity_NN and_CC its_PP$ associated_VBN cellular_JJ functions_NNS ._SENT Antibodies_NNS |_SYM Polyclonal_JJ antibodies_NNS against_IN the_DT C-terminal_NP FIP200_NP (_( residues_NNS 1374_CD --_: 1591_CD ;_: anti-FIP200C_NN ;_: )_) ,_, rabbit_NN antiserum_NN against_IN FAK_NP ,_, mouse_NN mAb_NN KT3_NP ,_, and_CC mouse_NN mAb_NN 12CA5_JJ that_WDT recognize_VBP the_DT hemagglutinin_NN (_( HA_NP )_) epitope_NN tag_NN have_VBP been_VBN described_VBN previously_RB ._SENT Antiserum_NN against_IN the_DT N-terminal_JJ segment_NN of_IN FIP200_NP was_VBD prepared_VBN in_IN rabbits_NNS using_VBG a_DT glutathione_NN S-transferase_NN (GST)-fusion_NN protein_NN containing_VBG residues_NNS 1_CD --_: 373_CD within_IN N_NP terminus_NN of_IN FIP200_NP ._SENT Anti-FIP200N_NN antibodies_NNS were_VBD then_RB affinity_NN purified_VBN from_IN the_DT antiserum_NN using_VBG the_DT same_JJ fusion_NN protein_NN immobilized_VBN on_IN glutathione-Sepharose_NN as_IN an_DT affinity_NN matrix_NN ._SENT Mouse_NN mAbs_NNS against_IN FAK_NP ,_, Pyk2_NP ,_, and_CC paxillin_NN ,_, and_CC antiphosphotyrosine_NN antibody_NN ,_, PY20_NP ,_, were_VBD purchased_VBN from_IN Transduction_NP Laboratories_NPS (_( Lexington_NP ,_, KY_NP )_) ._SENT Rabbit_NN antibody_NN against_IN phosphorylated_JJ Y397_JJ of_IN FAK_NP (_( anti-pFAKY397_JJ )_) was_VBD purchased_VBN from_IN Biosource_NP (_( Camarillo_NP ,_, CA_NP )_) ._SENT Rabbit_NN anti-HA_NP (_( HA_NP probe_NN )_) ,_, mouse_NN mAb_NN against_IN Myc_NP epitope_NN tag_NN (_( 9E10_NN )_) ,_, and_CC rabbit_VB polyclonal_JJ anti-green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) were_VBD obtained_VBN from_IN Santa_NP Cruz_NP Biotechnology_NP (_( Santa_NP Cruz_NP ,_, CA_NP )_) ._SENT Rabbit_NN polyclonal_JJ anti-beta-Gal_NN was_VBD from_IN 5_CD prime-_NN 3_CD prime_NN ,_, Inc._NP (_( Boulder_NP ,_, CO_NP )_) ._SENT Mouse_NN monoclonal_NN anti-Flag_NN ,_, anti-BrdU_NP ,_, fluorescein-conjugated_JJ goat_NN anti-rabbit_NN immunoglobulin_NN (_( Ig_NP )_) G_NP ,_, and_CC rhodamine-conjugated_JJ goat_NN anti-mouse_NN IgG_NP were_VBD purchased_VBN from_IN Sigma_NP (_( St._NP Louis_NP ,_, MO_NP )_) ._SENT Construction_NN of_IN Expression_NP Vectors_NP |_SYM The_DT expression_NN vectors_VBZ pSG5-FIP200_NN ,_, pSG5-N-terminal-FIP_NN (_( NT-FIP_NP )_) ,_, and_CC pSG5-C-terminal-FIP_NN (_( CT-FIP_NN )_) encoding_VBG Flag-tagged_JJ full-length_JJ NT-FIP_NP and_CC CT-FIP_NP have_VBP been_VBN described_VBN previously_RB ._SENT pSG5-middle_NN domain-FIP_NN (_( MD-FIP_NN )_) encoding_VBG Flag-tagged_JJ middle_JJ domain_NN of_IN FIP200_NP was_VBD generated_VBN by_IN amplifying_VBG residues_NNS 639-1373_CD of_IN FIP200_NP using_VBG primers_NNS with_IN EcoRV_NP site_NN at_IN the_DT 5_CD '_POS end_NN and_CC BglIsite_NN at_IN the_DT 3_CD '_POS site_NN ._SENT The_DT region_NN was_VBD subsequently_RB cloned_VBN into_IN the_DT corresponding_JJ cloning_VBG sites_NNS in_IN pSG5_JJ vector_NN ._SENT Similarly_RB ,_, expression_NN vectors_NNS pKH3-FIP200_NN ,_, pKH3-NT-FIP_NN ,_, pKH3-MD-FIP_NN ,_, and_CC pKH3-CT-FIP_NN encoding_VBG HA-tagged_NP FIP200_NP or_CC fragments_NNS were_VBD generated_VBN by_IN amplifying_VBG residues_NNS 1_CD --_: 1591_CD ,_, 1_CD --_: 638_CD ,_, 639-1373_CD ,_, and_CC 1374_CD --_: 1591_CD with_IN the_DT addition_NN of_IN SmaI_NP site_NN at_IN 5_CD '_POS end_NN and_CC EcoRV_NP site_NN at_IN 3_CD '_POS end_NN ._SENT These_DT fragments_NNS were_VBD subsequently_RB digested_VBN and_CC cloned_VBN into_IN corresponding_JJ cloning_VBG sites_NNS in_IN pKH3_JJ vector_NN ._SENT pGEX-CT-FIP_NN has_VBZ been_VBN described_VBN previously_RB ._SENT pGEX-NT-FIP_NN was_VBD constructed_VBN by_IN performing_VBG polymerase_NN chain_NN reaction_NN (_( PCR_NP )_) to_TO generate_VB a_DT 1.1-kb_JJ N-terminal_JJ fragment_NN corresponding_JJ to_TO residues_NNS 1_CD --_: 373_CD within_IN NT-FIP_NN with_IN the_DT addition_NN of_IN SmaI_NP site_NN at_IN the_DT 5_CD '_POS end_NN and_CC EcoRV_NP site_NN at_IN the_DT 3_CD '_POS end_NN ._SENT This_DT fragment_NN was_VBD digested_VBN with_IN SmaI_NP and_CC EcoRV_NP and_CC was_VBD inserted_VBN into_IN the_DT corresponding_JJ cloning_VBG site_NN of_IN pGEX-2T_NN vector_NN ._SENT pGEX-MD-FIP_NN was_VBD generated_VBN by_IN amplifying_VBG region_NN corresponding_JJ to_TO residue_NN 639-1373_CD of_IN plasmid_NN encoding_VBG full-length-FIP200_NN ._SENT The_DT primers_NNS included_VBD a_DT SmaI_NP site_NN at_IN 5_CD '_POS end_NN and_CC EcoRV_NP site_NN at_IN 3_CD '_POS end_NN ._SENT The_DT fragment_NN was_VBD digested_VBN with_IN SmaI_NP and_CC EcoRV_NP and_CC was_VBD inserted_VBN into_IN corresponding_JJ sites_NNS into_IN the_DT pGEX-2T_JJ vector_NN ._SENT FAK_NP segment_NN containing_VBG N-terminal_JJ domain_NN (_( NT-FAK_NP )_) was_VBD generated_VBN by_IN PCR_NP amplification_NN using_VBG the_DT forward_RB (_( 5'-CTGGATCCATGGCAGCTTACCTTG-3_NP '_POS )_) and_CC reverse_VB (_( 5'-ATGATATCTTAAGTATCTTC_NP TTCATC-3_NP '_POS )_) primers_NNS ._SENT The_DT PCR_NP product_NN was_VBD digested_VBN with_IN BamHI_NP and_CC EcoRV_NP and_CC was_VBD cloned_VBN into_IN pKH3_NN at_IN BamHI_NP and_CC SmaI_NP site_NN to_TO generate_VB pKH3-NT-FAK_NN ._SENT FAK_NP segment_NN containing_VBG the_DT kinase_NN domain_NN (_( KD-FAK_NP )_) was_VBD generated_VBN by_IN PCR_NP amplification_NN using_VBG the_DT forward_RB (_( 5'-ATGATATCAACCAGAGATTATGAAATTC-3_NP '_POS )_) and_CC reverse_VB (_( 5'-GCTTTAAATTAAGTAAACCTGGGTCGTCTAC-3_NP '_POS )_) primers_NNS ._SENT The_DT PCR_NP product_NN was_VBD digested_VBN with_IN EcoRV_NP and_CC DraI_NP and_CC was_VBD cloned_VBN into_IN pKH3_NN at_IN SmaI_NP site_NN to_TO generate_VB pKH3-KD-FAK_NN ._SENT The_DT same_JJ primers_NNS were_VBD used_VBN to_TO amplify_VB the_DT kinase_NN domain_NN with_IN K454_NP to_TO R_NP mutation_NN using_VBG a_DT FAK_NP cDNA_NN with_IN this_DT mutation_NN as_IN the_DT template_NN ._SENT This_DT fragment_NN was_VBD then_RB cloned_VBN into_IN pKH3_JJ vector_NN to_TO make_VB the_DT HA-tagged_JJ KDKR_NP construct_NN ._SENT The_DT expression_NN vectors_VBZ encoding_VBG full-length_JJ HA-tagged_NP FAK_NP and_CC the_DT C-terminal_NP FAK_NP have_VBP been_VBN described_VBN previously_RB ._SENT The_DT kinase_NN domain_NN of_IN Pyk2_NP was_VBD generated_VBN by_IN PCR_NP amplification_NN using_VBG the_DT sense_NN (_( 5'-CCAGGATCCGGCATTGCCCGTGAAGATG-3_NP '_POS )_) and_CC antisense_NN (_( 5'-ATGAATTCGCTTCACACCAGCTCGGTG-3_NP '_POS )_) oligonucleotides_NNS ._SENT The_DT product_NN was_VBD then_RB inserted_VBN into_IN pKH3_NN to_TO generate_VB pKH3-KD-Pyk2_NN ._SENT The_DT vector_NN encoding_VBG full-length_JJ Pyk2_NN has_VBZ been_VBN described_VBN previously_RB ._SENT The_DT expression_NN vectors_VBZ encoding_VBG HA-tagged_JJ Grb7_JJ and_CC the_DT control_NN protein_NN (_( Grb7-SH2_NP domain_NN )_) have_VBP been_VBN described_VBN previously_RB ._SENT Expression_NN vectors_NNS encoding_VBG GFP-paxillin_NP ,_, HA-Shc_NP ,_, and_CC Myc-p130cas_NP were_VBD kind_NN gifts_NNS from_IN Drs._NP C._NP Turner_NP (_( Upstate_NP Medical_NP Center_NP ,_, Syracuse_NP ,_, NY_NP )_) ,_, D._NP Schlaepfer_NP (_( Scripps_NP Research_NP Institute_NP ,_, La_NP Jolla_NP ,_, CA_NP )_) and_CC S._NP Hanks_NP (_( Vanderbilt_NP University_NP ,_, TN_NP )_) ,_, respectively_RB ._SENT In_IN Vitro_NP Binding_NP |_SYM GST_JJ fusion_NN proteins_NNS were_VBD produced_VBN and_CC purified_VBN using_VBG a_DT protease-defective_JJ Escherichia_NP coli_NNS strain_VBP BL21-Dex_NP ,_, as_RB described_VBN previously_RB ._SENT GST_JJ fusion_NN proteins_NNS (_( 3_CD mug_NN )_) were_VBD immobilized_VBN on_IN glutathione-agarose_JJ beads_NNS and_CC were_VBD then_RB incubated_VBN for_IN 4_CD h_NN at_IN 4C_JJ with_IN lysates_NNS (_( 200_CD mug_NN )_) prepared_VBN from_IN 293_CD cells_NNS that_WDT had_VBD been_VBN transfected_VBN with_IN expression_NN vectors_NNS encoding_VBG kinase_NN domain_NN of_IN Pyk2_NP ,_, HA-FAK_NP ,_, or_CC its_PP$ fragments_NNS ._SENT After_IN washing_NN ,_, the_DT bound_JJ proteins_NNS were_VBD analyzed_VBN by_IN Western_NP blotting_VBG with_IN anti-HA_NN (_( 1:2000_CD )_) as_IN described_VBN below_IN ._SENT For_IN binding_VBG to_TO the_DT recombinant_JJ FAK_NP ,_, His-tagged_VBD recombinant_JJ FAK_NP was_VBD purified_VBN from_IN baculovirus-infected_JJ sf21_JJ cells_NNS as_RB described_VBD previously_RB ._SENT GST-fusion_NN proteins_NNS (_( 5_CD mug_NN )_) were_VBD equalized_VBN for_IN amount_NN of_IN glutathione_NN agarose_NN beads_NNS and_CC were_VBD incubated_VBN with_IN 1_CD mug_NN of_IN purified_VBN His-tagged_JJ FAK_NP in_IN binding_VBG buffer_NN (_( 20_CD mM_NP Tris_NP ,_, pH_NN 8.0_CD ,_, 137_CD mM_NP NaCl_NP ,_, 1_CD mM_NP MgCl2_NP ,_, and_CC 1_CD %_NN Triton_NP )_) overnight_RB at_IN 4C_JJ with_IN rotation_NN ._SENT The_DT samples_NNS were_VBD then_RB washed_VBN five_CD times_NNS with_IN binding_JJ buffer_NN ,_, boiled_VBN in_IN SDS_NP buffer_NN ,_, resolved_VBN by_IN SDS-PAGE_NP ,_, and_CC western_JJ blotted_VBN with_IN alpha-FAK_NN antibody_NN ._SENT Immunoprecipitation_NP and_CC Western_NP Blot_NP |_SYM For_IN most_JJS experiments_NNS ,_, cells_NNS were_VBD lysed_VBN with_IN 1_CD %_NN NP-40_JJ lysis_NN buffer_NN (_( 20_CD mM_NP Tris_NP ,_, pH_NN 8.0_CD ,_, 137_CD mM_NP NaCl_NP ,_, 1_CD %_NN Nonidet_NP P40_NP ,_, 10_CD %_NN glycerol_NN ,_, 1_CD mM_NP Na3VO4_NP ,_, 1_CD mM_NP phenyl_NN methyl_NN sulfoxide_NN ,_, 10_CD mug/ml_NN aprotinin_NN ,_, and_CC 20_CD mug/ml_NN leupeptin_NN )_) ._SENT For_IN experiments_NNS to_TO detect_VB phosphorylation_NN of_IN HA-Shc_NP ,_, cells_NNS were_VBD lysed_VBN in_IN the_DT modified_JJ RIPA_NP lysis_NN buffer_NN (_( 50_CD mM_NP Tris_NP ,_, pH_NN 7.5_CD ,_, 150_CD mM_NP NaCl_NP ,_, 0.3_CD %_NN sodium_NN deoxycholate_NN ,_, 0.1_CD %_NN Nonidet_NP P-40_NP ,_, 10_CD %_NN glycerol_NN ,_, 1.5_CD mM_NP MgCl2_NP ,_, 1_CD mM_NP EDTA_NP ,_, 0.2_CD mM_NP EGTA_NP ,_, 20_CD mM_NP NaF_NP ,_, 25_CD muM_NN ZnCl2_NP ,_, 1_CD mM_NP NaVO4_NP ,_, 1_CD mM_NP phenyl_NN methyl_NN sulfoxide_NN ,_, 10_CD mug/ml_NN aprotinin_NN ,_, and_CC 2_CD mug/ml_NN leupeptin_NN )_) as_RB described_VBD previously_RB ._SENT Immunoprecipitation_NN was_VBD carried_VBN out_RP at_IN 4C_JJ by_IN incubating_VBG cell_NN lysates_NNS for_IN 2_CD --_: 4_CD h_NN with_IN indicated_JJ antibodies_NNS followed_VBN by_IN incubation_NN for_IN 1_CD h_NN with_IN Protein_NP A-Sepharose_NP or_CC Protein_NP G-Plus_NP ._SENT Immunoprecipitates_NNS were_VBD washed_VBN three_CD times_NNS in_IN lysis_NN buffer_NN without_IN protease_NN inhibitors_NNS ._SENT The_DT beads_NNS were_VBD then_RB resuspended_VBN in_IN SDS-PAGE_NP sample_NN buffer_NN ,_, boiled_VBN for_IN 5_CD min_NN ,_, and_CC resolved_VBN by_IN SDS-PAGE_NP ._SENT Western_NP blotting_VBG was_VBD performed_VBN with_IN appropriate_JJ antibodies_NNS as_RB indicated_VBD ,_, using_VBG the_DT Amersham_NP enhanced_JJ chemiluminescent_JJ system_NN (_( Arlington_NP Heights_NP ,_, IL_NP )_) ,_, as_RB described_VBN previously_RB ._SENT In_IN some_DT experiments_NNS ,_, whole_JJ cell_NN lysates_NNS were_VBD analyzed_VBN directly_RB by_IN Western_NP blotting_VBG ._SENT FAK_NP In_IN Vitro_NP Kinase_NP Assay_NP |_SYM FAK_NP was_VBD immunoprecipitated_VBN from_IN Chinese_JJ hamster_NN ovary_NN cells_NNS overexpressing_VBG FAK_NP ._SENT Aliquots_NNS of_IN the_DT immune_JJ complex_NN were_VBD assayed_VBN for_IN kinase_NN activity_NN as_RB described_VBD previously_RB in_IN the_DT presence_NN of_IN various_JJ amounts_NNS of_IN GST_JJ fusion_NN proteins_NNS containing_VBG FIP200_NP segments_NNS or_CC GST_JJ alone_RB ._SENT Measurement_NN of_IN Cell_NP Spreading_NP |_SYM NIH3T3_JJ cells_NNS were_VBD transfected_VBN using_VBG the_DT LipofectAmine_NP and_CC PLUS_NP transfection_NN reagents_NNS (_( Life_NP Technologies_NP ,_, Grand_NP Island_NP ,_, NY_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT One_CD day_NN after_IN transfection_NN ,_, the_DT cells_NNS were_VBD replated_VBN on_IN FN_NP (_( 10_CD mug/ml_NN )_) ,_, fixed_VBN in_IN formaldehyde_NN ,_, and_CC processed_VBN for_IN immunofluorescence_NN staining_VBG (_( see_VB below_IN )_) ._SENT Alternatively_RB ,_, cells_NNS were_VBD cotransfected_VBN with_IN a_DT plasmid_NN encoding_VBG beta-gal_NN along_IN with_IN the_DT indicated_JJ vectors_NNS ._SENT One_CD day_NN after_IN transfection_NN ,_, cells_NNS were_VBD replated_VBN on_IN FN_NP (_( 10_CD mug/ml_NN )_) for_IN 30_CD min_NN ,_, fixed_VBN ,_, and_CC assayed_VBN for_IN beta-gal_JJ activity_NN as_RB described_VBD previously_RB ._SENT At_IN least_JJS 60_CD positively_RB transfected_JJ cells_NNS (_( blue_JJ )_) were_VBD counted_VBN for_IN their_PP$ spreading_VBG phenotype_NN in_IN each_DT transfection_NN in_IN three_CD independent_JJ experiments_NNS ._SENT Cell_NN Migration_NP Assays_NP |_SYM NIH_NP 3T3_JJ cells_NNS were_VBD cotransfected_VBN with_IN various_JJ vectors_NNS along_IN with_IN a_DT plasmid_NN encoding_VBG GFP_NP in_IN 7:1_CD ratio_NN using_VBG the_DT LipofectAmine_NP and_CC PLUS_NP transfection_NN reagents_NNS (_( Life_NP Technologies_NPS )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT One_CD or_CC 2_CD d_NN after_IN transfection_NN ,_, the_DT cell_NN monolayer_NN was_VBD wounded_VBN with_IN a_DT p10_JJ tip_NN ._SENT The_DT plates_NNS were_VBD then_RB washed_VBN and_CC incubated_VBN at_IN 37C_JJ in_IN growth_NN medium_NN for_IN 8_CD h._JJ Phase_NP contrast_NN and_CC fluorescence_NN images_NNS were_VBD taken_VBN every_DT 2_CD h_NN until_IN the_DT wound_NN closed_VBD (_( similar10_NN h_NN )_) ._SENT The_DT rate_NN of_IN migration_NN was_VBD calculated_VBN by_IN measuring_VBG the_DT distance_NN moved_VBD toward_IN the_DT center_NN of_IN the_DT wound_NN in_IN 8_CD h._JJ Motility_NN assays_NNS using_VBG OMAware_NP were_VBD as_RB described_VBN previously_RB ._SENT Measurement_NN of_IN Cell_NP Cycle_NP Progression_NP by_IN BrdU_NP Incorporation_NP |_SYM BrdU_NP incorporation_NN assays_NNS were_VBD performed_VBN as_IN described_VBN previously_RB ._SENT Briefly_RB ,_, NIH_NP 3T3_JJ cells_NNS were_VBD transfected_VBN using_VBG the_DT LipofectAmine_NP and_CC PLUS_NP transfection_NN reagents_NNS (_( Life_NP Technologies_NPS )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT The_DT subconfluent_JJ transfected_JJ cells_NNS were_VBD serum_NN starved_VBN for_IN 24_CD h_NN in_IN DME_NP with_IN 0.5_CD %_NN CS_NP ._SENT They_PP were_VBD then_RB replated_JJ on_IN FN_NP (_( 10_CD mug/ml_NN )_) and_CC incubated_VBN for_IN 16_CD h_NN with_IN 100_CD muM_NN BrdU_NP (_( Sigma_NP )_) in_IN DME_NP plus_CC 10_CD %_NN CS_NP ._SENT For_IN experiments_NNS with_IN FAK-KDKR_NP mutant_NN ,_, cells_NNS were_VBD serum_NN starved_VBN for_IN 30_CD h_NN in_IN 0.5_CD %_NN serum_NN ._SENT They_PP were_VBD then_RB replated_JJ on_IN FN_NP (_( 10_CD mug/ml_NN )_) or_CC poly-l-lysine_NP (_( PLL_NP ;_: 0.1_CD mg/ml_NN )_) and_CC incubated_VBN for_IN 20_CD h_NN with_IN 100_CD muM_NN BrdU_NP in_IN 1_CD %_NN serum_NN ._SENT Cellular_NP DNA_NP was_VBD digested_VBN with_IN 0.5_CD U/mul_NP DNaseI_NP (_( ,_, Beverly_NP ,_, MA_NP )_) for_IN 30_CD min_NN at_IN 37C_JJ ._SENT Cells_NNS were_VBD then_RB processed_VBN for_IN double_JJ immunofluorescence_NN staining_VBG with_IN polyclonal_JJ anti-HA_NP (_( HA_NP probe_NN ;_: 1:300_LS )_) and_CC monoclonal_NN anti-BrdU_NN (_( 1:300_CD )_) as_IN described_VBN below_IN ._SENT At_IN least_JJS 80_CD positively_RB transfected_JJ cells_NNS (_( as_RB recognized_VBN by_IN anti-HA_NP )_) in_IN multiple_JJ fields_NNS were_VBD scored_VBN for_IN BrdU_NP staining_VBG in_IN each_DT independent_JJ experiment_NN ._SENT For_IN FAK_NP rescue_NN experiments_NNS ,_, an_DT expression_NN plasmid_NN encoding_VBG beta-Gal_NN was_VBD also_RB included_VBN in_IN transfections_NNS ._SENT Cells_NNS were_VBD then_RB analyzed_VBN for_IN BrdU_NP incorporation_NN as_RB described_VBD above_IN ,_, except_IN that_WDT the_DT positively_RB transfected_JJ cells_NNS were_VBD identified_VBN by_IN immunostaining_NN with_IN polyclonal_JJ anti-beta-Gal_NN ._SENT The_DT percentage_NN of_IN BrdU+/beta-Gal+_NP cells_NNS was_VBD determined_VBN by_IN analyzing_NN 40_CD --_: 50_CD beta-Gal+_NN cells_NNS for_IN each_DT transfection_NN in_IN multiple_JJ fields_NNS ._SENT Immunofluorescence_NP Staining_NP |_SYM Cells_NP were_VBD processed_VBN for_IN immunofluorescence_NN staining_VBG as_RB described_VBN previously_RB ._SENT The_DT primary_JJ antibodies_NNS used_VBN were_VBD polyclonal_JJ anti-FIP200N_NN (_( 1:200_CD )_) ,_, monoclonal_NN anti-FAK_NN (_( 1:100_CD )_) ,_, polyclonal_JJ anti-HA_NN (_( 1:200_CD )_) ,_, polyclonal_JJ anti-beta-Gal_NN (_( 1:300_CD )_) ,_, monoclonal_NN anti-BrdU_NN (_( 1:200_CD )_) ,_, and_CC monoclonal_NN antivinculin_NN (_( 1:50_CD )_) ._SENT The_DT secondary_JJ antibodies_NNS used_VBN were_VBD fluorescein-conjugated_VBN goat_NN anti-rabbit_NN IgG_NP (_( 1:300_CD )_) and_CC rhodamine-conjugated_JJ goat_NN anti-mouse_NN IgG_NP (_( 1:200_CD )_) ._SENT The_DT cells_NNS were_VBD mounted_VBN on_IN Slowfade_NP (_( Molecular_NP Probes_NP ,_, Eugene_NP ,_, OR_NP )_) and_CC examined_VBN ._SENT The_DT image_NN of_IN stained_VBN cells_NNS was_VBD captured_VBN using_VBG an_DT immunofluorescence_NN microscope_NN (_( ,_, Tokyo_NP ,_, Japan_NP )_) and_CC a_DT charged-coupled_JJ device_NN camera_NN ._SENT Association_NP of_IN Endogenous_NP FIP200_NP with_IN FAK_NP |_SYM To_TO explore_VB the_DT mechanism_NN and_CC potential_JJ function_NN of_IN FIP200_NP interaction_NN with_IN FAK_NP ,_, we_PP first_RB analyzed_VBD interaction_NN of_IN endogenous_JJ FIP200_NP and_CC FAK_NP ._SENT Lysates_NNS were_VBD prepared_VBN from_IN cells_NNS that_WDT had_VBD been_VBN suspended_VBN or_CC replated_VBN on_IN FN_NP ,_, type_NN IV_CD collagen_NN ,_, or_CC type_VB I_PP collagen_NN ._SENT They_PP were_VBD immunoprecipitated_VBN by_IN an_DT antibody_NN against_IN FIP200_NP and_CC then_RB subjected_VBN to_TO western_JJ blotting_VBG with_IN anti-FAK_NP to_TO detect_VB associated_JJ FAK_NP in_IN the_DT immune_JJ complexes_NNS ._SENT Figure_VB A_DT shows_NNS association_NN of_IN endogenous_JJ FAK_NP with_IN FIP200_NP and_CC that_IN the_DT association_NN was_VBD decreased_VBN upon_IN cell_NN adhesion_NN to_TO FN_NP ,_, and_CC to_TO a_DT less_JJR extent_NN ,_, type_NN IV_CD collagens_NNS or_CC type_VB I_PP collagen_NN ._SENT Western_JJ blotting_VBG of_IN the_DT immunoprecipitates_NNS with_IN another_DT antibody_NN against_IN FIP200_NP showed_VBD similar_JJ amounts_NNS of_IN FIP200_NP precipitated_VBD from_IN cells_NNS lysates_NNS under_IN these_DT different_JJ conditions_NNS (_( Figure_NP B_NP )_) ._SENT Consistent_JJ with_IN previous_JJ studies_NNS ,_, cell_NN adhesion_NN to_TO FN_NP ,_, and_CC to_TO a_DT less_JJR extent_NN ,_, type_NN IV_CD collagens_NNS or_CC type_VB I_PP collagen_NN ,_, activated_VBN FAK_NP that_WDT lead_VBP to_TO increased_VBN FAK_NP autophosphorylation_NN at_IN Y397_JJ (_( Figure_NP ,_, C_NP and_CC D_NP )_) ._SENT These_DT results_NNS suggest_VBP that_IN FIP200_NP dissociation_NN from_IN FAK_NP is_VBZ correlated_VBN with_IN FAK_NP activation_NN during_IN cell_NN adhesion_NN ,_, which_WDT is_VBZ consistent_JJ with_IN our_PP$ previous_JJ finding_NN that_IN FIP200_NP may_MD also_RB function_VB as_IN a_DT protein_NN inhibitor_NN for_IN FAK_NP ._SENT These_DT coimmunoprecipitation_NN analyses_NNS also_RB detected_VBD association_NN of_IN endogenous_JJ FIP200_NP and_CC FAK_NP in_IN several_JJ other_JJ cell_NN lines_NNS ,_, including_VBG rat_NN aortic_JJ smooth_JJ muscle_NN cells_NNS ,_, 293_CD cells_NNS ,_, and_CC NIH_NP 3T3_JJ cells_NNS (_( S._NP Abbi_NP and_CC J._NP Guan_NP ,_, unpublished_JJ data_NNS )_) ._SENT Figure_NP 1_CD |_SYM Association_NN and_CC localization_NN of_IN FIP200_NP and_CC FAK_NP ._SENT Association_NP and_CC localization_NN of_IN FIP200_NP and_CC FAK_NP ._SENT (_( A-D_NP )_) Lysates_NP were_VBD prepared_VBN from_IN MDA-MB231_JJ breast_NN carcinoma_NN cells_NNS that_WDT had_VBD been_VBN suspended_VBN ,_, or_CC replated_JJ on_IN FN_NP ,_, type_NN IV_CD collagen_NN ,_, or_CC type_VB I_PP collagen_NN ,_, as_RB indicated_VBN ._SENT They_PP were_VBD immunoprecipitated_VBN by_IN anti-FIP200N_NN and_CC then_RB analyzed_VBN by_IN Western_NP blotting_VBG with_IN anti-FAK_NP (_( A_NP )_) or_CC anti-FIP200C_NP (_( B_NP )_) ._SENT The_DT whole_JJ cell_NN lysates_NNS (_( WCL_NP )_) were_VBD also_RB analyzed_VBN directly_RB by_IN Western_NP blotting_VBG with_IN anti-pFAKY397_JJ (_( C_NP )_) or_CC anti-FAK_NP (_( D_NP )_) ._SENT (_( E_NP )_) NIH_NP 3T3_JJ cells_NNS (_( top_JJ panels_NNS )_) or_CC ECV304_NP cells_NNS transfected_VBN with_IN FIP200_NP (_( bottom_NN panels_NNS )_) were_VBD processed_VBN for_IN immunofluorescence_NN as_IN described_VBN in_IN "_`` Materials_NNS and_CC Methods_NNS "_'' using_VBG anti-FIP200N_NP or_CC anti-FAK_NP ,_, as_RB indicated_VBN ._SENT Examples_NNS of_IN colocalization_NN of_IN FIP200_NP and_CC FAK_NP in_IN peripheral_JJ focal_JJ contacts_NNS are_VBP marked_VBN by_IN arrows_NNS ._SENT Our_PP$ previous_JJ studies_NNS suggested_VBD that_IN FIP200_NP was_VBD predominantly_RB localized_VBN in_IN the_DT cytoplasm_NN ._SENT Using_VBG the_DT new_JJ polyclonal_JJ antibody_NN against_IN the_DT N-terminal_JJ domain_NN of_IN FIP200_NP ,_, we_PP detected_VBD presence_NN of_IN endogenous_JJ FIP200_NP in_IN the_DT focal_JJ contacts_NNS in_IN the_DT cell_NN periphery_NN in_IN addition_NN to_TO the_DT cytoplasmic_JJ staining_VBG in_IN a_DT fraction_NN of_IN the_DT cells_NNS (_( Figure_NP E_NP )_) ._SENT Costaining_NP with_IN anti-FAK_NP (_( Figure_NP E_NP ,_, top_JJ panels_NNS )_) or_CC anti-vinculin_NP (_( S._NP Abbi_NP and_CC J._NP Guan_NP ,_, unpublished_JJ data_NNS )_) showed_VBD partial_JJ colocalization_NN of_IN FIP200_NP with_IN FAK_NP and_CC vinculin_NP in_IN the_DT focal_JJ contacts_NNS ._SENT This_DT partial_JJ colocalization_NN of_IN FIP200_NP with_IN FAK_NP in_IN focal_JJ contacts_NNS in_IN the_DT periphery_NN of_IN the_DT cells_NNS was_VBD also_RB seen_VBN more_RBR clearly_RB in_IN cells_NNS transfected_VBN with_IN the_DT full-length_JJ FIP200_NP (_( Figure_NP E_NP ,_, bottom_NN panels_NNS )_) ._SENT These_DT results_NNS suggested_VBD that_IN at_IN least_JJS part_NN of_IN FIP200_NP was_VBD partially_RB colocalized_VBN with_IN FAK_NP ._SENT FIP200_NP Association_NP with_IN FAK_NP through_IN Multiple_NP Interaction_NP Domains_NP |_SYM To_TO define_VB the_DT FAK-binding_NP domains_NNS within_IN FIP200_NP ,_, we_PP coexpressed_VBD HA-tagged_NP FAK_NP with_IN Flag-tagged_NP FIP200_NP and_CC several_JJ FIP200_NP segments_NNS (_( see_VB Figure_NP A_NP )_) in_IN 293_CD cells_NNS ._SENT Immunoprecipitations_NNS were_VBD performed_VBN with_IN anti-Flag_NN antibody_NN and_CC were_VBD followed_VBN by_IN western_JJ blotting_VBG with_IN anti-FAK_NN antibody_NN ._SENT As_IN shown_VBN in_IN Figure_NP B_NP ,_, FAK_NP is_VBZ coprecipitated_VBN with_IN the_DT full-length_JJ FIP200_NP and_CC the_DT CT-FIP_NP ,_, which_WDT is_VBZ consistent_JJ with_IN our_PP$ previous_JJ result_NN ._SENT Surprisingly_RB ,_, however_RB ,_, both_CC the_DT FIP200_NP NT-FIP_NP and_CC MD-FIP_NP segments_NNS also_RB associated_VBN with_IN FAK_NP in_IN these_DT experiments_NNS ._SENT We_PP then_RB performed_VBD in_IN vitro-binding_VBG assays_NNS to_TO determine_VB whether_IN all_DT three_CD FIP200_NP segments_NNS bound_VBN to_TO the_DT same_JJ region_NN on_IN FAK_NP ._SENT Figure_NP C_NP shows_VBZ that_IN GST_JJ fusion_NN proteins_NNS containing_VBG any_DT of_IN the_DT three_CD FIP200_NP segments_NNS bound_VBN to_TO the_DT full-length_JJ FAK_NP ,_, whereas_IN GST_NP alone_RB did_VBD not_RB ._SENT Interestingly_RB ,_, GST_JJ fusion_NN proteins_NNS containing_VBG NT-FIP_NP or_CC MD-FIP_NP bound_VBN to_TO the_DT kinase_NN domain_NN of_IN FAK_NP ,_, whereas_IN GST_JJ fusion_NN protein_NN containing_VBG CT-FIP_NP bound_VBN to_TO the_DT N-terminal_JJ region_NN of_IN FAK_NP ._SENT None_NN of_IN the_DT GST_JJ fusion_NN proteins_NNS bound_VBN to_TO the_DT C-terminal_JJ region_NN of_IN FAK_NP ._SENT The_DT interaction_NN of_IN NT-FIP_NP and_CC MD-FIP_NP with_IN the_DT kinase_NN domain_NN of_IN FAK_NP was_VBD specific_JJ because_IN they_PP did_VBD not_RB interact_VB with_IN the_DT kinase_NN domain_NN of_IN Pyk2_NP ,_, a_DT homolog_NN of_IN FAK_NP ,_, in_IN the_DT same_JJ experiment_NN ._SENT Likewise_RB ,_, GST_NP alone_RB did_VBD not_RB bind_VB to_TO any_DT of_IN the_DT FAK_NP domains_NNS as_RB expected_VBN ._SENT To_TO examine_VB whether_IN all_DT three_CD FIP200_NP fragments_NNS bound_VBN to_TO FAK_NP directly_RB or_CC indirectly_RB through_IN other_JJ proteins_NNS in_IN the_DT 293_CD cell_NN lysates_NNS ,_, we_PP used_VBD purified_VBN recombinant_JJ FAK_NP from_IN insect_NN cells_NNS in_IN the_DT same_JJ in_IN vitro-binding_VBG assays_NNS ._SENT Figure_NP D_NP shows_VBZ that_IN GST_JJ fusion_NN proteins_NNS containing_VBG NT-FIP_NP ,_, MD-FIP_NP ,_, or_CC CT-FIP_NP ,_, but_CC not_RB GST_JJ alone_RB ,_, bound_VBN to_TO the_DT recombinant_JJ FAK_NP ._SENT Taken_VBN together_RB ,_, these_DT results_NNS demonstrate_VBP that_IN FIP200_NP could_MD associate_VB directly_RB and_CC specifically_RB with_IN FAK_NP through_IN multiple_JJ interaction_NN domains_NNS ._SENT Figure_NP 2_CD |_SYM Analysis_NN of_IN FIP200_NP association_NN with_IN FAK_NP ._SENT Analysis_NN of_IN FIP200_NP association_NN with_IN FAK_NP ._SENT (_( A_NP )_) A_DT schematic_NN of_IN full-length_JJ FIP200_NP is_VBZ shown_VBN on_IN top_NN ._SENT NT-FIP_NP and_CC CT-FIP_NP segments_NNS ,_, and_CC MD-FIP_NP of_IN FIP200_NP are_VBP shown_VBN below_RB ._SENT (_( B_LS )_) 293T_JJ cells_NNS were_VBD transfected_VBN with_IN an_DT expression_NN vector_NN encoding_VBG HA-FAK_NP and_CC vectors_NNS encoding_VBG Flag-FIP200_NP ,_, its_PP$ segments_NNS or_CC empty_JJ vector_NN control_NN (_( V_CD )_) ,_, as_RB indicated_VBN ._SENT Lysates_NNS were_VBD immunoprecipitated_VBN with_IN anti-Flag_NN followed_VBN by_IN Western_NP blotting_VBG with_IN anti-FAK_NP to_TO detect_VB associated_JJ HA-FAK_NP (_( top_JJ panel_NN )_) or_CC with_IN anti-Flag_NN to_TO verify_VB similar_JJ amounts_NNS of_IN samples_NNS in_IN the_DT immunoprecipitates_NNS (_( bottom_JJ panel_NN ;_: Flag-FIP200_NP and_CC segments_NNS are_VBP marked_VBN by_IN arrowheads_NNS )_) ._SENT (_( C_LS )_) 293T_JJ cells_NNS were_VBD transfected_VBN with_IN vectors_NNS encoding_VBG HA-FAK_NP (_( WT_NP )_) or_CC its_PP$ fragments_NNS (_( N-terminal_NP ,_, kinase_NN domain_NN and_CC C-terminal_JJ )_) or_CC with_IN kinase_NN domain_NN of_IN Pyk2_NP ,_, as_RB indicated_VBN ._SENT Lysates_NNS from_IN the_DT transfected_JJ cells_NNS were_VBD then_RB incubated_VBN with_IN immobilized_VBN GST_JJ fusion_NN proteins_NNS containing_VBG FIP200_NP segments_NNS or_CC GST_JJ alone_RB ,_, as_RB indicated_VBN ._SENT The_DT bound_JJ proteins_NNS were_VBD resolved_VBN on_IN SDS-PAGE_NP and_CC were_VBD analyzed_VBN by_IN Western_NP blotting_VBG with_IN mAb_NP 12CA5_NP (_( anti-HA_NP )_) ._SENT (_( D_NP )_) Equal_NP amounts_NNS of_IN immobilized_VBN GST-fusion_NN proteins_NNS containing_VBG FIP200_NP fragments_NNS ,_, or_CC GST_NP alone_RB ,_, were_VBD incubated_VBN with_IN 1_CD mug_NN of_IN recombinant_JJ FAK_NP ._SENT The_DT bound_JJ proteins_NNS were_VBD resolved_VBN on_IN SDS-PAGE_NP and_CC were_VBD analyzed_VBN by_IN Western_NP blotting_VBG with_IN anti-FAK_NP (_( top_JJ panel_NN )_) ._SENT The_DT membrane_NN was_VBD also_RB stained_VBN with_IN Ponceau_NP S_NP stain_NN to_TO detect_VB GST-fusion_NP proteins_NNS (_( marked_VBN with_IN arrowheads_NNS ;_: bottom_JJ panel_NN )_) ._SENT FIP200_NP Inhibition_NP of_IN FAK_NP Kinase_NP Activity_NP and_CC Autophosphorylation_NP |_SYM The_DT binding_NN of_IN FIP200_NP to_TO FAK_NP kinase_NN domain_NN raised_VBD the_DT possibility_NN that_IN FIP200_NP may_MD have_VB an_DT effect_NN on_IN FAK_NP kinase_NN activity_NN ._SENT To_TO test_VB this_DT directly_RB ,_, we_PP performed_VBD FAK_NP in_IN vitro_NP kinase_NN assays_NNS using_VBG E4Y1_JJ as_IN an_DT exogenous_JJ substrate_NN in_IN the_DT presence_NN of_IN different_JJ amounts_NNS of_IN purified_VBN GST_JJ fusion_NN protein_NN containing_VBG the_DT FIP200_NP segments_NNS or_CC GST_JJ alone_RB as_IN a_DT control_NN ._SENT Figure_NP A_NP shows_VBZ that_IN the_DT GST_JJ fusion_NN proteins_NNS containing_VBG the_DT NT-FIP_NP and_CC MD-FIP_NP inhibited_VBD FAK_NP kinase_NN activity_NN ,_, whereas_IN GST_NP alone_RB did_VBD not_RB have_VB any_DT effect_NN ._SENT GST_JJ fusion_NN protein_NN containing_VBG NT-FIP_NP showed_VBD a_DT significantly_RB greater_JJR inhibitory_JJ effect_NN than_IN GST_JJ fusion_NN protein_NN containing_VBG CT-FIP_NP ._SENT GST_JJ fusion_NN protein_NN containing_VBG MD-FIP_NP showed_VBD an_DT intermediary_JJ activity_NN ,_, which_WDT was_VBD also_RB significantly_RB higher_JJR than_IN GST_JJ fusion_NN protein_NN containing_VBG CT-FIP_NP ._SENT In_IN particular_JJ ,_, at_IN lower_JJR concentrations_NNS (_( e.g._FW ,_, <5_JJ pmol/reaction_NN )_) ,_, GST_JJ fusion_NN proteins_NNS containing_VBG NT-FIP_NP or_CC MD-FIP_NP reduced_VBD FAK_NP kinase_NN activity_NN ,_, whereas_IN CT-FIP_NP did_VBD not_RB ,_, suggesting_VBG that_IN NT-FIP_NP and_CC MD-FIP_NP are_VBP more_RBR effective_JJ than_IN CT-FIP_NP in_IN the_DT inhibition_NN of_IN FAK_NP kinase_NN activity_NN in_IN vitro_NN ._SENT These_DT FIP200_NP segments_NNS also_RB inhibited_VBD FAK_NP from_IN SYF_NP cells_NNS (_( deficient_JJ in_IN Src_NP ,_, Yes_NP ,_, and_CC Fyn_NP expression_NN )_) to_TO the_DT same_JJ extent_NN as_IN FAK_NP from_IN wild-type_NN control_NN cells_NNS (_( S._NP Abbi_NP and_CC J._NP Guan_NP ,_, unpublished_JJ data_NNS )_) ,_, suggesting_VBG that_IN FIP200_NP inhibited_VBD the_DT kinase_NN activity_NN of_IN FAK_NP directly_RB ,_, but_CC not_RB through_IN its_PP$ potential_JJ effects_NNS on_IN the_DT associated_JJ Src_NP family_NN kinases_NNS ._SENT Figure_NP 3_CD |_SYM Inhibition_NN of_IN FAK_NP activity_NN by_IN FIP200_NP ._SENT Inhibition_NN of_IN FAK_NP activity_NN by_IN FIP200_NP ._SENT (_( A_NP )_) The_DT kinase_NN activity_NN of_IN FAK_NP was_VBD assayed_VBN in_IN the_DT presence_NN of_IN various_JJ amounts_NNS of_IN GST_JJ fusion_NN proteins_NNS containing_VBG FIP200_NP segments_NNS ,_, or_CC GST_NP alone_RB ,_, as_RB indicated_VBN ._SENT Relative_JJ kinase_NN activities_NNS were_VBD normalized_VBN to_TO FAK_NP activity_NN in_IN the_DT absence_NN of_IN GST_JJ fusion_NN protein_NN ._SENT The_DT mean_JJ +-_NN SE_NN of_IN relative_JJ kinase_NN activities_NNS from_IN three_CD independent_JJ experiments_NNS are_VBP shown_VBN ._SENT The_DT inset_NN shows_VBZ Coomassie_NP blue_NN staining_VBG of_IN a_DT representation_NN preparation_NN of_IN the_DT fusion_NN proteins_NNS (_( 1_CD ,_, GST-NT-FIP_NP ;_: 2_LS ,_, GST-MD-FIP_NP ;_: and_CC 3_CD ,_, GST-CT-FIP_NP )_) ._SENT (_( B_LS )_) 293T_JJ cells_NNS were_VBD cotransfected_VBN with_IN plasmid_NN encoding_VBG HA-FAK_NP and_CC HA-FIP200_NP ,_, its_PP$ segments_NNS ,_, or_CC vector_NN control_NN ,_, as_RB indicated_VBN ._SENT One_CD day_NN after_IN transfection_NN ,_, cells_NNS were_VBD trypsinized_VBN and_CC either_RB kept_VBN in_IN suspension_NN (_( S_NP )_) or_CC replated_JJ on_IN FN_NP (_( 10_CD mug/ml_NN )_) for_IN 30_CD min_NN ._SENT They_PP were_VBD then_RB lysed_VBN and_CC immunoprecipitated_VBN with_IN anti-HA_NN followed_VBN by_IN Western_NP blotting_VBG with_IN PY20_NP to_TO detect_VB FAK_NP phosphorylation_NN (_( top_JJ panel_NN )_) or_CC anti-HA_NP to_TO verify_VB similar_JJ FAK_NP expression_NN levels_NNS (_( middle_JJ panel_NN )_) ._SENT The_DT corresponding_JJ whole_JJ cell_NN lysates_NNS (_( WCL_NP )_) were_VBD resolved_VBN on_IN a_DT SDS-PAGE_NP gel_NN and_CC were_VBD western_JJ blotted_VBN with_IN anti-HA_NP to_TO detect_VB similar_JJ amounts_NNS of_IN FIP200_NP and_CC its_PP$ fragments_NNS (_( marked_VBN by_IN arrowheads_NNS ,_, bottom_JJ panel_NN )_) ._SENT We_PP next_RB examined_VBD the_DT effect_NN of_IN FIP200_NP and_CC its_PP$ segments_NNS on_IN cell_NN adhesion-induced_JJ FAK_NP phosphorylation_NN in_IN intact_JJ cells_NNS ._SENT As_IN shown_VBN in_IN Figure_NP B_NP (_( Top_JJ and_CC middle_JJ panels_NNS )_) ,_, expression_NN of_IN FIP200_NP suppressed_VBD tyrosine_NN phosphorylation_NN of_IN FAK_NP after_IN adhesion_NN to_TO FN_NP (_( Figure_NP B_NP ,_, compare_NN lanes_NNS FIP200_NP and_CC V_CD )_) ._SENT Expression_NN of_IN NT-FIP_NP or_CC MD-FIP_NP also_RB inhibited_VBD FAK_NP phosphorylation_NN (_( Figure_NP B_NP ,_, compare_NN lanes_NNS NT-FIP_NP and_CC MD-FIP_NP with_IN lane_NN V_CD )_) ,_, whereas_IN CT-FIP_NP did_VBD not_RB have_VB any_DT effect_NN (_( Figure_NP B_NP ,_, compare_NN lanes_NNS CT-FIP_NN and_CC V_CD )_) ._SENT Similar_JJ expression_NN levels_NNS of_IN FIP200_NP fragments_NNS were_VBD verified_VBN by_IN western_JJ blotting_VBG with_IN anti-HA_NP (_( Figure_NP B_NP ,_, lower_JJR panel_NN )_) ._SENT Together_RB ,_, these_DT results_NNS indicate_VBP that_IN binding_VBG of_IN FIP200_NP to_TO FAK_NP through_IN interactions_NNS at_IN different_JJ domains_NNS could_MD inhibit_VB FAK_NP kinase_NN activity_NN in_IN vitro_NN ._SENT However_RB ,_, they_PP also_RB suggest_VBP that_IN the_DT quantitative_JJ difference_NN of_IN the_DT in_IN vitro_NP inhibitory_JJ activity_NN of_IN FIP200_NP segments_NNS could_MD lead_VB to_TO a_DT differential_JJ inhibition_NN of_IN FAK_NP activity_NN in_IN intact_JJ cells_NNS by_IN NT-FIP_NP and_CC MD-FIP_NP ,_, but_CC not_RB by_IN CT-FIP_NP ._SENT Effects_NNS of_IN FIP200_NP on_IN FAK_NP Downstream_NP Signaling_NP |_SYM Activation_NN and_CC autophosphorylation_NN of_IN FAK_NP have_VBP been_VBN suggested_VBN to_TO lead_VB to_TO tyrosine_NN phosphorylation_NN of_IN several_JJ other_JJ cellular_JJ proteins_NNS ,_, including_VBG paxillin_NN ,_, p130cas_NNS ,_, Grb7_JJ ,_, and_CC Shc_NP ._SENT Therefore_RB ,_, we_PP examined_VBD the_DT effects_NNS of_IN FIP200_NP on_IN the_DT FAK-promoted_JJ activation_NN of_IN these_DT downstream_JJ targets_NNS ._SENT Figure_NN shows_VBZ that_DT overexpression_NN of_IN FAK_NP induced_VBD tyrosine_NN phosphorylation_NN of_IN all_DT four_CD potential_JJ substrates_NNS ,_, paxillin_NN ,_, p130cas_NNS ,_, Grb7_JJ ,_, and_CC Shc_NP ,_, as_RB observed_VBD previously_RB ._SENT Interestingly_RB ,_, overexpression_NN of_IN NT-FIP_NP ,_, which_WDT had_VBD maximum_JJ inhibition_NN of_IN FAK_NP activation_NN and_CC phosphorylation_NN among_IN the_DT segments_NNS (_( see_VB Figure_NP )_) ,_, reduced_VBN cell_NN adhesion-dependent_NN paxillin_NN and_CC Shc_NN phosphorylation_NN by_IN FAK_NP (_( Figure_NP ,_, A_NP and_CC C_NP )_) ,_, but_CC had_VBD little_JJ effect_NN on_IN p130cas_NNS and_CC Grb7_JJ phosphorylation_NN (_( Figure_NP ,_, B_NP and_CC D_NP )_) ._SENT The_DT mechanism_NN of_IN FIP200_NP 's_POS selective_JJ inhibition_NN of_IN FAK_NP downstream_JJ targets_NNS is_VBZ unknown_JJ ._SENT It_PP is_VBZ possible_JJ that_IN the_DT threshold_NN activity_NN of_IN FAK_NP required_VBN for_IN its_PP$ phosphorylation_NN of_IN these_DT substrates_NNS is_VBZ different_JJ ._SENT Thus_RB ,_, inhibition_NN of_IN FAK_NP by_IN FIP200_NP under_IN these_DT experimental_JJ conditions_NNS could_MD be_VB sufficient_JJ to_TO inhibit_VB paxillin_NP and_CC Shc_NP phosphorylation_NN ,_, but_CC not_RB for_IN p130cas_NNS and_CC Grb7_JJ phosphorylation_NN ._SENT Figure_NP 4_CD |_SYM Effects_VBZ of_IN FIP200_NP on_IN FAK_NP downstream_IN signaling_VBG ._SENT Effects_NNS of_IN FIP200_NP on_IN FAK_NP downstream_IN signaling_VBG ._SENT 293_CD cells_NNS were_VBD cotransfected_VBN with_IN plasmids_NNS encoding_VBG FAK_NP ,_, NT-FIP_NP ,_, or_CC empty_JJ vector_NN as_IN controls_NNS ,_, along_RB with_IN vectors_NNS encoding_VBG GFP-paxillin_NP (_( A_NP )_) ,_, Myc-p130cas_NP (_( B_NP )_) ,_, HA-Shc_NP (_( C_NP )_) ,_, or_CC HA-Grb7_JJ (_( D_NP )_) ,_, as_RB indicated_VBN ._SENT One_CD day_NN after_IN transfection_NN ,_, cells_NNS were_VBD trypsinized_VBN and_CC replated_VBN on_IN FN_NP (_( 10_CD mug/ml_NN )_) for_IN 30_CD min_NN ._SENT Whole_JJ cell_NN lysates_NNS were_VBD then_RB immunoprecipitated_VBN with_IN anti-GFP_NP ,_, anti-Myc_NP ,_, or_CC anti-HA_NN to_TO pull-down_JJ epitope-tagged_JJ paxillin_NN ,_, p130cas_NNS ,_, Shc_NP ,_, and_CC Grb7_JJ ,_, respectively_RB ._SENT The_DT immune_JJ complexes_NNS were_VBD then_RB analyzed_VBN by_IN Western_NP blotting_VBG with_IN PY20_NP to_TO detect_VB their_PP$ phosphorylation_NN (_( top_JJ panels_NNS )_) ,_, or_CC with_IN antipaxillin_NP ,_, anti-Myc_NP ,_, or_CC anti-HA_NP to_TO show_VB their_PP$ respective_JJ expression_NN levels_NNS (_( bottom_JJ panels_NNS )_) ._SENT The_DT position_NN of_IN HA-Shc_NP is_VBZ indicated_VBN by_IN arrows_NNS in_IN C._NP Effects_NPS of_IN FIP200_NP on_IN FAK-Dependent_NP Cell_NP Spreading_NP and_CC Migration_NP |_SYM We_PP next_RB examined_VBD the_DT effects_NNS of_IN FIP200_NP on_IN FAK-regulated_JJ cellular_JJ functions_NNS ,_, including_VBG cell_NN spreading_VBG and_CC migration_NN ,_, and_CC cell_NN cycle_NN progression_NN ._SENT To_TO study_VB cell_NN spreading_VBG ,_, we_PP transiently_RB transfected_VBD NIH3T3_JJ cells_NNS with_IN the_DT expression_NN vectors_VBZ encoding_VBG FIP200_NP or_CC its_PP$ fragments_NNS (_( see_VB Figure_NP A_NP )_) ._SENT The_DT effects_NNS on_IN cell_NN spreading_VBG on_IN FN_NP were_VBD assessed_VBN initially_RB by_IN immunofluorescent_JJ staining_VBG with_IN anti-HA_NN antibody_NN to_TO mark_VB the_DT positively_RB transfected_JJ cells_NNS ,_, and_CC with_IN anti-vinculin_NN antibodies_NNS to_TO mark_VB the_DT background_NN untransfected_JJ cells_NNS in_IN the_DT same_JJ field_NN ._SENT Figure_NP A_NP shows_VBZ that_IN transfection_NN of_IN the_DT cells_NNS with_IN full-length_JJ FIP200_NP prevented_VBD cell_NN spreading_VBG on_IN FN_NP (_( Figure_NP ,_, top_JJ panels_NNS )_) ,_, whereas_IN expression_NN of_IN the_DT CT-FIP_NN did_VBD not_RB affect_VB cell_NN spreading_VBG (_( Figure_NP ,_, bottom_NN panels_NNS )_) ._SENT Similar_JJ studies_NNS showed_VBD that_DT expression_NN of_IN NT-FIP_NP or_CC MD-FIP_NP also_RB inhibited_VBD cell_NN spreading_VBG (_( S._NP Abbi_NP and_CC J._NP Guan_NP ,_, unpublished_JJ data_NNS )_) ._SENT The_DT differences_NNS in_IN cell_NN spreading_VBG were_VBD still_RB apparent_JJ 4_CD h_NN after_IN replating_VBG on_IN FN_NP (_( S._NP Abbi_NP and_CC J._NP Guan_NP ,_, unpublished_JJ data_NNS )_) ,_, although_IN all_DT cells_NNS were_VBD completely_RB spread_VBN after_IN overnight_JJ incubation_NN (_( see_VB Figure_NP A_NP )_) ,_, suggesting_VBG that_DT inhibition_NN of_IN cell_NN spreading_VBG by_IN FIP200_NP was_VBD transient_JJ ._SENT We_PP also_RB used_VBD cotransfection_NN of_IN an_DT expression_NN vector_NN encoding_VBG beta-gal_JJ to_TO identify_VB the_DT positively_RB transfected_JJ cells_NNS in_IN the_DT cell_NN spreading_VBG assays_NNS ._SENT Figure_NP B_NP shows_VBZ similar_JJ results_NNS using_VBG this_DT method_NN ._SENT Expression_NN of_IN FIP-200_NP ,_, NT-FIP_NP ,_, or_CC MD-FIP_NP inhibited_VBD cell_NN spreading_VBG by_IN similar50_JJ %_NN compared_VBN with_IN control_NN untransfected_JJ cells_NNS or_CC cells_NNS expressing_VBG CT-FIP_NP ._SENT The_DT correlation_NN of_IN cell_NN spreading_VBG inhibition_NN by_IN NT-FIP_NP and_CC MD-FIP_NP ,_, but_CC not_RB CT-FIP_NP ,_, with_IN their_PP$ inhibition_NN of_IN FAK_NP activity_NN (_( see_VB Figure_NP )_) suggested_VBD that_IN FIP200_NP might_MD inhibit_VB cell_NN spreading_VBG by_IN its_PP$ inhibition_NN of_IN endogenous_JJ FAK_NP functions_NNS ._SENT Consistent_JJ with_IN this_DT possibility_NN ,_, coexpression_NN of_IN FAK_NP with_IN FIP200_NP rescued_VBD inhibition_NN of_IN cell_NN spreading_VBG by_IN FIP200_NP (_( compare_VB the_DT first_JJ and_CC the_DT last_JJ lane_NN in_IN Figure_NP B_NP )_) ,_, although_IN overexpression_NN of_IN FAK_NP alone_RB had_VBD no_DT effect_NN on_IN cell_NN spreading_VBG under_IN these_DT conditions_NNS ._SENT Western_JJ blotting_VBG of_IN aliquots_NNS of_IN lysates_NNS from_IN the_DT transfected_JJ cells_NNS showed_VBD similar_JJ expression_NN levels_NNS of_IN FIP200_NP and_CC its_PP$ fragments_NNS and_CC a_DT lack_NN of_IN effects_NNS of_IN FAK_NP coexpression_NN on_IN the_DT levels_NNS of_IN FIP200_NP (_( Figure_NP ,_, C_NP and_CC D_NP )_) ._SENT Figure_NP 5_CD |_SYM Inhibition_NN of_IN cell_NN spreading_VBG by_IN FIP200_NP ._SENT Inhibition_NN of_IN cell_NN spreading_VBG by_IN FIP200_NP ._SENT (_( A_NP )_) NIH3T3_NP cells_NNS were_VBD transfected_VBN with_IN expression_NN vectors_NNS encoding_VBG FIP200_NP or_CC CT-FIP_NP ,_, as_RB indicated_VBN ._SENT One_CD day_NN after_IN transfection_NN ,_, cells_NNS were_VBD trypsinized_VBN and_CC replated_VBN on_IN FN_NP (_( 10_CD mug/ml_NN )_) for_IN 45_CD min_NN ._SENT Cells_NNS were_VBD fixed_VBN and_CC processed_VBN for_IN immunostaining_NN with_IN anti-HA_NP to_TO detect_VB the_DT positively_RB transfected_JJ cells_NNS (_( green_JJ )_) and_CC with_IN antivinculin_NN to_TO visualize_VB all_DT cells_NNS (_( red_JJ )_) ._SENT (_( B-D_NP )_) NIH3T3_NP cells_NNS were_VBD transfected_VBN with_IN vectors_NNS encoding_VBG FIP200_NP ,_, its_PP$ segments_NNS ,_, or_CC empty_JJ vector_NN control_NN ,_, and_CC plasmid_NP encoding_VBG a_DT HA-tagged_NP FAK_NP (_( in_IN some_DT experiments_NNS )_) ,_, along_RB with_IN a_DT plasmid_NN encoding_VBG beta-Gal_NN ,_, as_RB indicated_VBN ._SENT One_CD day_NN after_IN transfection_NN ,_, cells_NNS were_VBD trypsinized_VBN and_CC replated_VBN on_IN FN_NP (_( 10_CD mug/ml_NN )_) for_IN 45_CD min_NN ._SENT The_DT cells_NNS were_VBD then_RB fixed_VBN ,_, and_CC beta-Gal_JJ assays_NNS were_VBD performed_VBN to_TO identify_VB the_DT positively_RB transfected_JJ cells_NNS ._SENT The_DT mean_JJ +-_NN SE_NN of_IN percentage_NN of_IN spread_NN cells_NNS from_IN three_CD independent_JJ experiments_NNS are_VBP shown_VBN (_( B_NP )_) ._SENT Aliquots_NNS of_IN whole_JJ cell_NN lysates_NNS (_( WCL_NP )_) were_VBD also_RB analyzed_VBN directly_RB by_IN Western_NP blotting_VBG using_VBG anti-Flag_NN to_TO detect_VB FIP200_NP and_CC its_PP$ fragments_NNS (_( C_NP )_) or_CC anti-HA_NP to_TO detect_VB FAK_NP (_( D_NP )_) ._SENT The_DT effect_NN of_IN FIP200_NP and_CC its_PP$ fragments_NNS on_IN cell_NN migration_NN was_VBD assessed_VBN by_IN using_VBG monolayer-wounding_JJ assays_NNS after_IN transient_JJ transfection_NN of_IN NIH3T3_JJ cells_NNS with_IN expression_NN vectors_NNS encoding_VBG FIP200_NP or_CC its_PP$ fragments_NNS along_RP with_IN a_DT plasmid_NN encoding_VBG GFP_NP ._SENT Phase_NN contrast_NN and_CC fluorescence_NN images_NNS were_VBD captured_VBN at_IN regular_JJ intervals_NNS after_IN wounding_VBG to_TO monitor_VB the_DT movement_NN of_IN cells_NNS from_IN the_DT wound_NN edge_NN to_TO the_DT center_NN of_IN the_DT wound_NN ._SENT The_DT rate_NN of_IN migration_NN was_VBD then_RB calculated_VBN for_IN transfected_JJ cells_NNS at_IN the_DT edge_NN of_IN the_DT wound_NN by_IN measuring_VBG the_DT distance_NN that_IN the_DT GFP-positive_JJ cells_NNS moved_VBN toward_IN the_DT center_NN of_IN the_DT wound_NN in_IN 8_CD h._NN As_IN shown_VBN in_IN Figure_NP A_NP ,_, cells_NNS transfected_VBD with_IN the_DT control_NN vector_NN (_( Figure_NP V_CD )_) moved_VBD toward_IN the_DT center_NN of_IN the_DT wound_NN at_IN the_DT same_JJ rate_NN as_IN the_DT surrounding_VBG untransfected_JJ cells_NNS ._SENT In_IN contrast_NN ,_, the_DT FIP200-transfected_NP cells_NNS moved_VBD much_RB less_JJR than_IN the_DT surrounding_VBG untransfected_JJ cells_NNS ._SENT Quantification_NN of_IN the_DT rate_NN of_IN migration_NN showed_VBD that_IN FIP200_NP ,_, NT-FIP_NP ,_, and_CC MD-FIP_NP inhibited_VBD cell_NN migration_NN by_IN similar60_NN --_: 80_CD %_NN ,_, whereas_IN CT-FIP_NP had_VBD no_DT effect_NN (_( Figure_NP B_NP )_) ._SENT Furthermore_RB ,_, coexpression_NN of_IN FAK_NP or_CC paxillin_NP with_IN FIP200_NP rescued_VBD inhibition_NN of_IN cell_NN migration_NN by_IN FIP200_NP (_( Figure_NP B_NP )_) ._SENT Similar_JJ results_NNS were_VBD also_RB obtained_VBN using_VBG an_DT alternative_JJ cell_NN migration_NN assays_NNS employing_VBG a_DT time-lapse_NN imaging-based_JJ computerized_JJ motility_NN analy_RB 